1995: Operations started with Isoniazid and Niacinamide APIs
2002: Commissioning of new manufacturing facility
2003: Started manufacturing Niacin for Jubilant Lifesciences under CRAMS model.
2007: Aceclofenac and Sucralose APIs were added.
2008: Commissioning of new production block.
2010: Clopidogrel Bisulphate and Etodolac manufacturing started.
2014: Several other APIs in Cardio and Neuro segment were developed.
2018: WHO-GMP approval
2019: Korean FDA approval and 2 CEP filings.
2020: WC Approval for Clopidogrel
2021: Commissioning of new state-of-the art 100KL Production Block and Pilot Plant for additional capacities.
Established in 1995, Cadchem Laboratories Limited (CLL) has progressed into the field of developing and manufacturing niche Active Pharmaceutical Ingredients (API) and its intermediates. It has emerged as a key pure play API manufacturer in Indian and Global markets with considerable growth and front-end presence.